C22H17F3N8O7S3 — CID 90056913
3-[2-[methylsulfonyl-[5-[(sulfamoylamino)methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-benzothiazol-6-yl]-N-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]benzamide (PubChem CID 90056913) has the molecular formula C22H17F3N8O7S3 and a molecular weight of 658.62 g/mol. Its IUPAC name is 3-[2-[methylsulfonyl-[5-[(sulfamoylamino)methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-benzothiazol-6-yl]-N-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]benzamide.
| Compound Name | 3-[2-[methylsulfonyl-[5-[(sulfamoylamino)methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-benzothiazol-6-yl]-N-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]benzamide |
|---|---|
| PubChem CID | 90056913 |
| Molecular Formula | C22H17F3N8O7S3 |
| Molecular Weight | 658.62 g/mol |
| Exact Mass | 658.03 |
| IUPAC Name | 3-[2-[methylsulfonyl-[5-[(sulfamoylamino)methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-benzothiazol-6-yl]-N-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]benzamide |
| SMILES | CS(=O)(=O)C(c1nnc(CNS(N)(=O)=O)o1)c1nc2ccc(-c3cccc(C(=O)Nc4nnc(C(F)(F)F)o4)c3)cc2s1 |
| InChI | InChI=1S/C22H17F3N8O7S3/c1-42(35,36)16(18-31-30-15(39-18)9-27-43(26,37)38)19-28-13-6-5-11(8-14(13)41-19)10-3-2-4-12(7-10)17(34)29-21-33-32-20(40-21)22(23,24)25/h2-8,16,27H,9H2,1H3,(H2,26,37,38)(H,29,33,34) |
| InChIKey | ROOSQDYZQURAFZ-UHFFFAOYSA-N |
| XLogP | 2.43 |
| TPSA | 226.16 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 43 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 658.62 |
| LogP ≤ 5 | 2.43 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 13 |